Journal
Journal of Parenteral & Enteral Nutrition.
Volume
45(6):1286-1292, 2021 08.
The objective was to determine 4% tetrasodium EDTA efficacy in preventing central line-associated bloodstream infections and reducing line occlusions in pediatric intestinal failure patients.